NCT02314351View on ClinicalTrials.gov

Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Migraine Disorders
Interventions
DRUG

Metoclopramide 10 mg

Intravenous form of metoclopramide is in the same appearance with placebo

DRUG

Placebo

Intravenous form of metoclopramide is in the same appearance with placebo

DRUG

Fentanyl

Intravenous fentanyl (1 mcg/kg), if pain persists at 30th minute

Trial Locations (1)

41000

Kocaeli University, Faculty of Medicine, Köseköy

All Listed Sponsors
lead

Kocaeli University

OTHER

NCT02314351 - Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial | Biotech Hunter | Biotech Hunter